The president of the American arm of the British Royal Shakespeare Company has given $5-million to help construct a new theater in Stratford-upon-Avon, England, reports The New York Times.

Chris Abele, a Milwaukee businessman whose father was a founder of the biotechnology company Boston Scientific, oversees his family’s philanthropic work as well as the Royal Shakespeare Company America. The American fund-raising arm of the theater has raised $10-million of a $25-million campaign to support the new $228-million theater.

Mr. Abele founded a Shakespeare company in Milwaukee in 2000, which made connections with its British counterpart. The collaboration has been a boon to the British troupe, which, like many British arts organizations, relies heavily on government assistance, The Times reports.